IrisVision
Pleasanton, US · Founded 2017 · Delaware corporation
IrisVision builds wearable, hands-free electronic low vision aids that magnify and enhance vision, along with personalized coaching, for people living with conditions such as macular degeneration, diabetic retinopathy, retinitis pigmentosa, and Stargardt disease. Developed with vision scientists and supported by NIH research, it operates at the intersection of digital health and vision science and is a Skipfour product.
Founders & leadership
IrisVision was founded in 2017 by Frank Werblin.

Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 1 round · 2021
▶$11.7MraisedMar 2022 · 29 investors · OtherRule 506(b)
- Syed Faiz AhmadDirector
- Narendra MulaniDirector
- Larry LeisureDirector
- Frank WerblinDirector
- Ammad KhanExecutive Officer, Director
- Offering amount
- $21.4M
- Amount sold
- $11.7M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with IrisVision for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does IrisVision do?
- IrisVision builds wearable, hands-free electronic low vision aids that magnify and enhance vision, along with personalized coaching, for people living with conditions such as macular degeneration, diabetic retinopathy, retinitis pigmentosa, and Stargardt disease. Developed with vision scientists and supported by NIH research, it operates at the intersection of digital health and vision science and is a Skipfour product.
- Who founded IrisVision?
- IrisVision was founded by Frank Werblin in 2017.
- How much funding has IrisVision raised?
- IrisVision has disclosed $11.7M raised across 1 round.
- Where is IrisVision headquartered?
- IrisVision is headquartered in Pleasanton, US.